Scott Praill serves as Executive at DelMar Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Scott Praill has executed 11 insider transactions totaling $92.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 5, 2017 involved purchasing 17,500 shares valued at $14.9K.
Scott Praill currently holds 47,366 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Praill has been a net buyer of DMPI stock. They have purchased $92.8K and sold $0 worth of shares.
Scott Praill's most recent insider trade was on Oct 5, 2017, when they purchased 17,500 shares at $0.85 per share.
Get notified when new Form 4 filings are submitted
| $3.20 |
| Discretionary |
| Jun 30, 2017 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Jun 26, 2017 | DMPI | $15.0K | Purchase | 4,167 | $3.60 | Discretionary |
| Jun 6, 2017 | DMPI | $19.9K | Purchase | 9,500 | $2.10 | Discretionary |
| Mar 31, 2017 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Dec 31, 2016 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Oct 3, 2016 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Jul 18, 2016 | DMPI | $461 | Other | 144 | $3.20 | Discretionary |
| Jul 16, 2015 | DMPI | $30.0K | Purchase | 50,000 | $0.60 | Discretionary |
| Mar 18, 2014 | DMPI | $13.0K | Purchase | 10,000 | $1.30 | Discretionary |